For the -month periods ended and our total stock-based compensation expense, which includes reversals of expense for certain forfeited or cancelled awards, was approximately and respectively. For the -month periods ended and our total stock-based compensation expense, which includes reversals of expense for certain forfeited or cancelled awards, was approximately and respectively. We have recorded any income tax benefit related to stock-based compensation in any of the -month or -month periods ended and

 

A summary of the status of our stock options as of and changes during the -month period then ended, is presented below.

 

		Nine Months Ended September 30 , 201 9
		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Contractual Life (in years)				Aggregate Intrinsic Value
Outstanding, January 1, 2019			157,915			$	24.82
Granted			95,250				5.89
Exercised			—				—
Canceled and Forfeited			(5,304	)			8.94
Expired			(9,041	)			31.21
Outstanding, September 30, 2019			238,820			$	17.38				7.4			$	—
Exercisable, September 30, 2019			80,157			$	33.13				5.0			$	—

 

 

A summary of the status of our unvested restricted stock as of and changes during the -month period then ended, is presented below.

 

		Nine Months Ended September 30 , 201 9
		Number of Shares				Weighted Average Grant-Date Fair Value
Unvested, January 1, 2019			5,000			$	7.42
Granted			15,000				2.75
Vested			(5,000	)			7.42
Forfeited			—				—
Unvested, September 30, 2019			15,000			$	2.75

 

As of there was approximately of total unrecognized compensation expense related to unvested stock-based awards, which we expect to recognize over the remaining weighted average vesting term of year.